English, Article edition: Law and Disorder: Critical Legal Issues in Disease Management James M. Jacobson; James M. Jorling; Neela A. Paykel

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/92043
Physical Description
  • article
Language
  • English

Edition details

Title
  • Law and Disorder: Critical Legal Issues in Disease Management
Author
  • James M. Jacobson
  • James M. Jorling
  • Neela A. Paykel
Physical Description
  • article
Notes
  • If the disease management industry succeeds in producing effective solutions to many of the problems besetting today's healthcare delivery systems (such as misalignment of financial and care incentives, poor customer service, failure to provide useful preventative care, and a dearth of empirical evidence of efficacy and efficiency), it may soon be a multi-billion dollar industry, with the potential for exponential future growth. Yet the law of disease management in the US has not kept pace with the rapid evolution of the industry. Federal and state regulators often mistakingly treat disease management enterprises as if they were healthcare providers or managed-care organisations. These misplaced legal paradigms do not provide adequate certainty and protection for all of the burgeoning companies that wish to comply with the laws yet still remain competitive. This uncertainty has raised nettlesome compliance problems, heightened legal liability, and, increasingly, even threatened disease management product and company viability. In diverse areas of the law - including licensure, telemedicine, liability and compliance, risk-sharing, fraud and abuse, physician incentives and medical record confidentiality - the absence of specific guidance has prompted government officials to take multiple, often conflicting approaches to regulating disease management companies and internal programmes. So far, companies have had to choose from two equally inefficacious remedies for this legal disorder: forego innovation to avoid `legal risk,' or accepts serious legal exposure to avoid `business risk'. Until payors, contractors, and providers advocate - and regulators and legislators promulgate - specific, objective, and appropriate legal and regulatory rules, disease management will continue to face an environment of increasing legal and competitive uncertainty.
  • Disease management programmes, Health policy, Pharmacoeconomics, Quality of care, Regulatory process, Reimbursement
  • RePEc:wkh:dmhout:v:6:y:1999:i:6:p:365-386
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment